Published in Trends Pharmacol Sci on May 01, 1995
Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+. Biochem J (1997) 1.49
Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140. Br J Pharmacol (1996) 0.81
[(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance. Br J Pharmacol (2000) 0.78
Changes in [3H]-UK 14304 binding to alpha 2-adrenoceptors in morphine-dependent guinea-pigs. Br J Pharmacol (1995) 0.75
Detection of receptor subtypes in radioligand binding studies. Trends Pharmacol Sci (1995) 0.75
Regulation of the cerebellar inositol 1,4,5-trisphosphate receptor by univalent cations. Biochem J (2004) 0.75
Interaction of membrane proteins and lipids with solubilizing detergents. Biochim Biophys Acta (2000) 3.46
From calcium blips to calcium puffs: theoretical analysis of the requirements for interchannel communication. Proc Natl Acad Sci U S A (1999) 1.86
Amphipols from A to Z. Annu Rev Biophys (2011) 1.75
Stochastic simulation of a single inositol 1,4,5-trisphosphate-sensitive Ca2+ channel reveals repetitive openings during 'blip-like' Ca2+ transients. Cell Calcium (1998) 1.37
Detergent structure and associated lipid as determinants in the stabilization of solubilized Ca2+-ATPase from sarcoplasmic reticulum. J Biol Chem (1989) 1.22
Kinetics of calcium dissociation from its high-affinity transport sites on sarcoplasmic reticulum ATPase. Biochemistry (1991) 1.21
Interaction of magnesium and inorganic phosphate with calcium-deprived sarcoplasmic reticulum adenosinetriphosphatase as reflected by organic solvent induced perturbation. Biochemistry (1985) 1.20
Rapid filtration studies of the effect of cytosolic Ca2+ on inositol 1,4,5-trisphosphate-induced 45Ca2+ release from cerebellar microsomes. J Biol Chem (1994) 1.18
In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides (1997) 1.15
Transient inositol 1,4,5-trisphosphate-induced Ca2+ release: a model based on regulatory Ca(2+)-binding sites along the permeation pathway. Proc Natl Acad Sci U S A (1994) 1.14
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem (2001) 1.14
Rapid filtration study of the phosphorylation-dependent dissociation of calcium from transport sites of purified sarcoplasmic reticulum ATPase and ATP modulation of the catalytic cycle. Biochemistry (1986) 1.10
Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol Pharmacol (1982) 1.09
Effects of phospholipids on binding of calcium to (Ca2(+)-Mg2(+)-ATPase. Biochemistry (1990) 1.08
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor. Peptides (2000) 1.08
Detection of Ca(2+)-binding proteins by electrophoretic migration in the presence of Ca2+ combined with 45Ca2+ overlay of protein blots. Anal Biochem (1991) 1.08
Mechanism of inhibition of the (Ca2(+)-Mg2+)-ATPase by nonylphenol. Biochemistry (1990) 1.06
Stopped flow and rapid quenching measurement of the transient steps induced by calcium binding to sarcoplasmic reticulum adenosine triphosphatase. Competition with Ca2+-independent phosphorylation. J Biol Chem (1981) 1.04
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides (1996) 1.04
Development of high affinity selective VIP1 receptor agonists. Peptides (1997) 1.04
Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett (1998) 1.04
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985) 1.03
Effect of magnesium on the calcium-dependent transient kinetics of sarcoplasmic reticulum ATPase, studied by stopped flow fluorescence and phosphorylation. J Biol Chem (1983) 1.01
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol (1989) 1.01
Do submaximal InsP3 concentrations only induce the partial discharge of permeabilized hepatocyte calcium pools because of the concomitant reduction of intraluminal Ca2+ concentration? FEBS Lett (1992) 1.00
Rapid kinetics of myo-inositol trisphosphate binding and dissociation in cerebellar microsomes. J Biol Chem (1994) 0.99
The cytoplasmic loop located between transmembrane segments 6 and 7 controls activation by Ca2+ of sarcoplasmic reticulum Ca2+-ATPase. J Biol Chem (1998) 0.99
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985) 0.99
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality. Peptides (1999) 0.99
Membrane solubilization by detergent: use of brominated phospholipids to evaluate the detergent-induced changes in Ca2+-ATPase/lipid interaction. Biochemistry (1989) 0.99
A new approach to the characterization of the B and A forms of DNA by I.R. spectroscopy. Biochem Biophys Res Commun (1973) 0.98
The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol (1983) 0.97
Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun (1994) 0.97
Thermodynamics of the interaction of insulin with its receptor. J Biol Chem (1979) 0.97
The two calcium ions initially bound to nonphosphorylated sarcoplasmic reticulum Ca(2+)-ATPase can no longer be kinetically distinguished when they dissociate from phosphorylated ATPase toward the lumen. Biochemistry (1991) 0.96
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides (1997) 0.95
Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom. FEBS Lett (1984) 0.95
A direct fluorescence study of the transient steps induced by calcium binding to sarcoplasmic reticulum ATPase. J Biol Chem (1980) 0.95
Calcium and inositol 1,4,5-trisphosphate-induced Ca2+ release. Science (1994) 0.95
Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides (1984) 0.95
Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol Pharmacol (1986) 0.94
Calcium control on InsP3-induced discharge of calcium from permeabilised hepatocyte pools. Cell Calcium (1993) 0.94
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors. Eur J Pharmacol (1998) 0.93
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands. Mol Pharmacol (1999) 0.93
Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. Receptors Channels (1999) 0.93
Binding of a nonionic detergent to membranes: flip-flop rate and location on the bilayer. Biochemistry (1987) 0.92
Do transmembrane segments in proteolyzed sarcoplasmic reticulum Ca(2+)-ATPase retain their functional Ca2+ binding properties after removal of cytoplasmic fragments by proteinase K? J Biol Chem (1995) 0.91
Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. Mol Pharmacol (1987) 0.90
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin. Biochem Biophys Res Commun (1996) 0.90
Characterization of the co-agonist effects of strontium and calcium on myo-inositol trisphosphate-dependent ion fluxes in cerebellar microsomes. Cell Calcium (1995) 0.90
The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. Mol Pharmacol (1983) 0.90
Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. Biochim Biophys Acta (1981) 0.89
Direct fluorescence measurements of Mg2+ binding to sarcoplasmic reticulum ATPase. J Biol Chem (1982) 0.89
The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. Biochim Biophys Acta (1997) 0.89
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix. Br J Pharmacol (2001) 0.88
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes. Eur J Pharmacol (1998) 0.88
Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. Biochim Biophys Acta (1981) 0.88
Kinetic characterization of the normal and detergent-perturbed reaction cycles of the sarcoplasmic reticulum calcium pump. Rate-limiting step(s) under different conditions. J Biol Chem (1986) 0.88
The cytoplasmic loop between putative transmembrane segments 6 and 7 in sarcoplasmic reticulum Ca2+-ATPase binds Ca2+ and is functionally important. J Biol Chem (1997) 0.88
Sarcoplasmic reticulum ATPase. Spin labeling detection of ligand-induced changes in the relative reactivities of certain sulfhydryl groups. J Biol Chem (1978) 0.87
Kinetic characterization of the perturbation by dodecylmaltoside of sarcoplasmic reticulum Ca(2+)-ATPase. Eur J Biochem (1992) 0.87
Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties. FEBS Lett (1984) 0.87
Effects of temperature and ethanol on agonist and antagonist binding to rat heart muscarinic receptors in the absence and presence of GTP. Biochem J (1985) 0.87
New functionally selective muscarinic agonists. Life Sci (1993) 0.86
The metal sites on sarcoplasmic reticulum membranes that bind lanthanide ions with the highest affinity are not the ATPase Ca2+ transport sites. J Biol Chem (1992) 0.86
Perturbation of the structure and function of a membranous Ca2+-ATPase by non-solubilizing concentrations of a non-ionic detergent. Eur J Biochem (1983) 0.86
The pH dependence of insulin binding. A quantitative study. J Biol Chem (1982) 0.86
Fluorescence energy transfer between ATPase monomers in sarcoplasmic reticulum reconstituted vesicles. Biochimie (1982) 0.86
Ca2(+)-induced conformational changes and location of Ca2+ transport sites in sarcoplasmic reticulum Ca2(+)-ATPase as detected by the use of proteolytic enzyme (V8). J Biol Chem (1990) 0.86
Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochem Pharmacol (1983) 0.85
Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas. Peptides (1986) 0.84
Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. Eur J Biochem (1997) 0.84
Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig. Regul Pept (1982) 0.84
Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. Biochem J (1983) 0.84
Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes. Eur J Pharmacol (1988) 0.84
Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation. Eur J Biochem (1999) 0.84
Brominated detergents as tools to study protein-detergent interactions. Eur J Biochem (1996) 0.84
Cancellation of the cooperativity of Ca2+ binding to sarcoplasmic reticulum Ca(2+)-ATPase by the non-ionic detergent dodecylmaltoside. Eur J Biochem (1994) 0.83
Cholinergic and alpha-adrenergic stimulation of prostaglandin release by dog thyroid in vitro. Endocrinology (1979) 0.83
Tryptophan octyl ester in detergent micelles of dodecylmaltoside: fluorescence properties and quenching by brominated detergent analogs. Biophys J (1999) 0.83
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. Eur J Biochem (1996) 0.83
A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.82
Sarcoplasmic reticulum adenosinetriphosphatase phosphorylation from inorganic phosphate. Theoretical and experimental reinvestigation. Biochemistry (1984) 0.82
Secretin receptors in human pancreatic membranes. Pancreas (1988) 0.82
Ligand binding to macromolecules or micelles: use of centrifugal ultrafiltration to measure low-affinity binding. Anal Biochem (1998) 0.82
The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats. Pflugers Arch (1983) 0.82
Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16. Cell Calcium (2001) 0.82
Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists. Trends Pharmacol Sci (1989) 0.82
Phosphoenzymes formed from Mg.ATP and Ca.ATP during pre-steady state kinetics of sarcoplasmic reticulum ATPase. J Biol Chem (1988) 0.81
Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes. FEBS Lett (1984) 0.81
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors. Biochim Biophys Acta (1996) 0.81
Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regul Pept (1994) 0.81
Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes. Biochim Biophys Acta (1984) 0.81
Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy. Mol Pharmacol (1982) 0.80
Spin labelled sarcoplasmic reticulum vesicles: Ca2+-induced spectral changes. FEBS Lett (1976) 0.80
Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists. Neuropharmacology (2003) 0.80
Evidence for multiple rat VPAC1 receptor states with different affinities for agonists. Cell Signal (1999) 0.80
Kinetic characterization of the normal and procaine-perturbed reaction cycles of the sarcoplasmic reticulum calcium pump. Eur J Biochem (1991) 0.80
Inhibitory effects of quinidine on rat heart muscarinic receptors. Life Sci (1984) 0.80